TGTX logo

TG Therapeutics (TGTX) Current Assets

Annual Current Assets

$217.51 M
+$49.23 M+29.26%

December 31, 2023

Summary

Performance

1-Year Change

+29.26%

3-Year Change

-64.44%

5-Year Change

+175.22%

15-Year Change

+133.08%

TGTX Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

65.51%
TGTX annual total current assets is higher than 65.51% of companies in Healthcare sector

High & Low

All-time High

$611.74 M
TGTX annual total current assets is currently -64.44% below its historical high of $611.74 million

3-Year Low

$168.27 M
TGTX annual total current assets is currently +29.26% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
TGTX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
TGTX next annual earnings announcement is scheduled for Feb 28, 2025

OtherTGTXbalance sheetmetrics:

Annual Total Assets

$329.59 M
TGTX annual total assets is $329.59 million

Annual Total Liabilities

$169.09 M
TGTX annual total liabilities is $169.09 million

Annual Current Liabilities

$53.72 M
TGTX annual total current liabilities is $53.72 million

Annual Total Long Term Liabilities

$115.36 M
TGTX annual total long term liabilities is $115.36 million

Quarterly Current Assets

$574.07 M
+$184.92 M+47.52%

September 30, 2024

Summary

Performance

3-Month Change

+47.52%

1-Year Change

+59.21%

3-Year Change

+175.24%

5-Year Change

+175.24%

TGTX Quarterly Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

81.65%
TGTX quarterly total current assets is higher than 81.65% of companies in Healthcare sector

High & Low

All-time High

$611.74 M
TGTX quarterly total current assets is currently -6.16% below its historical high of $611.74 million

3-Year Low

$168.27 M
TGTX quarterly total current assets is currently +241.15% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
TGTX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
TGTX next earnings announcement is scheduled for Feb 28, 2025

OtherTGTXbalance sheetmetrics:

Quarterly Total Assets

$586.01 M
TGTX quarterly total assets is $586.01 million

Quarterly Total Liabilities

$393.86 M
TGTX quarterly total liabilities is $393.86 million

Quarterly Current Liabilities

$125.11 M
TGTX quarterly total current liabilities is $125.11 million

Quarterly Long Term Liabilities

$268.74 M
TGTX quarterly total long term liabilities is $268.74 million

Current Assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

Annual Current Assets

$217.51 M
TGTX annual total current assets is $217.51 million

Annual Cash & Cash Equivalents

$92.93 M
TGTX annual cash & cash equivalents is $92.93 million

Annual Accounts Receivable

$51.09 M
TGTX annual accounts receivable is $51.09 million

Annual Inventory

$39.82 M
TGTX annual inventory is $39.82 million

TGTX Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+29.3%+59.2%
3 y3 years-64.4%+175.2%
5 y5 years+175.2%+175.2%

TGTX Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-34.3%+29.3%at high+241.2%
5 y5-year-64.4%+45.8%-6.2%+552.2%
alltimeall time-64.4%>+9999.0%-6.2%>+9999.0%

TG Therapeutics Current Assets History

DateAnnualQuarterly
Sep 2024
-
$574.07 M(+47.5%)
Jun 2024
-
$389.15 M(+7.9%)
Mar 2024
-
$360.58 M(+13.4%)
Dec 2023
$11.64 M(-54.0%)
$317.94 M(-0.4%)
Sep 2023
-
$319.11 M(+53.0%)
Jun 2023
-
$208.57 M(+12.9%)
Mar 2023
-
$184.78 M(+9.8%)
Dec 2022
$25.30 M(-48.0%)
$168.27 M(-8.0%)
Sep 2022
-
$182.92 M(-9.7%)
Jun 2022
-
$202.56 M(-16.4%)
Mar 2022
-
$242.22 M(-26.8%)
Dec 2021
$48.66 M(+250.1%)
$330.96 M(-11.0%)
Sep 2021
-
$371.78 M(-18.3%)
Jun 2021
-
$455.07 M(-14.9%)
Mar 2021
-
$535.01 M(-12.5%)
Dec 2020
$13.90 M(+0.3%)
$611.74 M(+135.0%)
Sep 2020
-
$260.33 M(-7.3%)
Jun 2020
-
$280.94 M(+219.2%)
Mar 2020
-
$88.02 M(-41.0%)
Dec 2019
$13.86 M(+202.4%)
$149.15 M(+85.6%)
Sep 2019
-
$80.36 M(-14.9%)
Jun 2019
-
$94.44 M(-10.1%)
Mar 2019
-
$105.06 M(+32.9%)
Dec 2018
$4.58 M(+12.8%)
$79.03 M(-28.0%)
Sep 2018
-
$109.74 M(-19.3%)
Jun 2018
-
$136.04 M(+16.3%)
Mar 2018
-
$116.96 M(+25.3%)
Dec 2017
$4.06 M(+3.7%)
$93.32 M(-4.4%)
Sep 2017
-
$97.66 M(+0.6%)
Jun 2017
-
$97.04 M(-18.4%)
Mar 2017
-
$118.96 M(+133.9%)
Dec 2016
$3.92 M(-85.3%)
$50.86 M(-28.7%)
Sep 2016
-
$71.33 M(+2.6%)
Jun 2016
-
$69.55 M(-1.5%)
Mar 2016
-
$70.58 M(-18.8%)
Dec 2015
$26.60 M(+1636.4%)
$86.87 M(-17.1%)
Sep 2015
-
$104.73 M(+1.0%)
Jun 2015
-
$103.73 M(-10.4%)
Mar 2015
-
$115.74 M(+35.8%)
Dec 2014
$1.53 M(-73.6%)
$85.22 M(+11.2%)
Sep 2014
-
$76.67 M(+55.6%)
Jun 2014
-
$49.29 M(-12.4%)
Mar 2014
-
$56.29 M(+33.1%)
Dec 2013
$5.81 M(+61.4%)
$42.30 M(-16.4%)
Sep 2013
-
$50.61 M(+257.2%)
Jun 2013
-
$14.17 M(-20.3%)
Mar 2013
-
$17.79 M(-3.7%)
Dec 2012
$3.60 M(-23.5%)
$18.48 M(-3.6%)
Sep 2012
-
$19.16 M(-6.3%)
Jun 2012
-
$20.46 M(-2.6%)
Mar 2012
-
$21.00 M(+113.5%)
Dec 2011
$4.70 M(-73.5%)
$9.84 M(+3042.4%)
Sep 2011
-
$313.00 K(-48.6%)
Jun 2011
-
$609.30 K(-32.4%)
Mar 2011
-
$901.60 K(+3.7%)
Dec 2010
$17.77 M
$869.20 K(-31.4%)
Sep 2010
-
$1.27 M(-30.6%)
DateAnnualQuarterly
Jun 2010
-
$1.83 M(-20.1%)
Mar 2010
-
$2.29 M(+766.8%)
Dec 2009
$101.90 K(-72.8%)
$263.70 K(+9.8%)
Sep 2009
-
$240.20 K(-54.2%)
Jun 2009
-
$524.80 K(-34.2%)
Mar 2009
-
$797.70 K(-8.8%)
Dec 2008
$374.70 K(+225.8%)
$874.20 K(+686.9%)
Sep 2008
-
$111.10 K(-84.4%)
Jun 2008
-
$711.90 K(-47.9%)
Mar 2008
-
$1.37 M(+57.9%)
Dec 2007
$115.00 K(-25.4%)
$865.50 K(-61.3%)
Sep 2007
-
$2.23 M(-56.5%)
Jun 2007
-
$5.14 M(-44.0%)
Mar 2007
-
$9.19 M(+179.1%)
Dec 2006
$154.20 K(-13.1%)
$3.29 M(-36.3%)
Sep 2006
-
$5.17 M(-31.3%)
Jun 2006
-
$7.53 M(-17.3%)
Mar 2006
-
$9.10 M(-17.5%)
Dec 2005
$177.40 K(-6.4%)
$11.03 M(-14.5%)
Sep 2005
-
$12.90 M(+434.6%)
Jun 2005
-
$2.41 M(-40.7%)
Mar 2005
-
$4.07 M(-25.5%)
Dec 2004
$189.50 K(+2268.8%)
$5.46 M(-26.5%)
Sep 2004
-
$7.43 M(-16.4%)
Jun 2004
-
$8.89 M(-10.3%)
Mar 2004
-
$9.92 M(+27.3%)
Dec 2003
$8000.00(>+9900.0%)
$7.79 M(+1637.5%)
Sep 2003
-
$448.40 K(-12.5%)
Jun 2003
-
$512.30 K(-57.4%)
Mar 2003
-
$1.20 M(-30.2%)
Dec 2002
$0.00(-100.0%)
$1.72 M(+276.2%)
Sep 2002
-
$457.50 K(-51.9%)
Jun 2002
-
$952.00 K(-0.1%)
Mar 2002
-
$953.30 K(-41.5%)
Dec 2001
$128.00 K(-56.9%)
$1.63 M(+248.5%)
Sep 2001
-
$467.80 K(-55.0%)
Jun 2001
-
$1.04 M(-60.2%)
Mar 2001
-
$2.61 M(-9.3%)
Dec 2000
$297.30 K(+48.6%)
$2.88 M(+3.7%)
Sep 2000
-
$2.78 M(+12.6%)
Jun 2000
-
$2.47 M(-29.0%)
Mar 2000
-
$3.47 M(-8.6%)
Dec 1999
$200.00 K(0.0%)
$3.80 M(-5.0%)
Sep 1999
-
$4.00 M(-11.1%)
Jun 1999
-
$4.50 M(-15.1%)
Mar 1999
-
$5.30 M(-15.9%)
Dec 1998
$200.00 K(-33.3%)
$6.30 M(-14.9%)
Sep 1998
-
$7.40 M(-12.9%)
Jun 1998
-
$8.50 M(+19.7%)
Mar 1998
-
$7.10 M(-16.5%)
Dec 1997
$300.00 K(+200.0%)
$8.50 M(-14.1%)
Sep 1997
-
$9.90 M(+312.5%)
Jun 1997
-
$2.40 M(+60.0%)
Mar 1997
-
$1.50 M(-34.8%)
Dec 1996
$100.00 K
$2.30 M(-30.3%)
Sep 1996
-
$3.30 M(+17.9%)
Jun 1996
-
$2.80 M

FAQ

  • What is TG Therapeutics annual total current assets?
  • What is the all time high annual current assets for TG Therapeutics?
  • What is TG Therapeutics annual current assets year-on-year change?
  • What is TG Therapeutics quarterly total current assets?
  • What is the all time high quarterly current assets for TG Therapeutics?
  • What is TG Therapeutics quarterly current assets year-on-year change?

What is TG Therapeutics annual total current assets?

The current annual current assets of TGTX is $217.51 M

What is the all time high annual current assets for TG Therapeutics?

TG Therapeutics all-time high annual total current assets is $611.74 M

What is TG Therapeutics annual current assets year-on-year change?

Over the past year, TGTX annual total current assets has changed by +$49.23 M (+29.26%)

What is TG Therapeutics quarterly total current assets?

The current quarterly current assets of TGTX is $574.07 M

What is the all time high quarterly current assets for TG Therapeutics?

TG Therapeutics all-time high quarterly total current assets is $611.74 M

What is TG Therapeutics quarterly current assets year-on-year change?

Over the past year, TGTX quarterly total current assets has changed by +$213.49 M (+59.21%)